Replies to post #347918 on Innovation Pharmaceuticals Inc (IPIX)

[LitesOut]

For the 2013 filings no quantitative or qualitative explanation was given because "No" was selected for the "significant change" question on the filing. For last week's filing in which he selected "Yes" he mainly mentioned the increase in R&D expense in this period (Q4 2020) compared to prior periods.